Ameren Corporation Financial Statements (AEE)

Ameren Corporationsmart-lab.ru   FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
Report date 04.08.2025 06.11.2025 18.02.2026 08.05.2026   08.05.2026
Currency USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 2 221 2 699 1 782 2 176   8 878
Operating Income, bln rub 411.0 825.0 360.0 532.0   2 128
EBITDA, bln rub ? 905.0 1 316 850.0 1 020   3 911
Net profit, bln rub ? 275.0 640.0 252.0 357.0   1 524
OCF, bln rub ? 862.0 1 104 956.0 421.0   3 343
CAPEX, bln rub ? 1 067 969.0 1 036 1 596   4 646
FCF, bln rub ? -205.0 135.0 -80.0 -1 175   -1 303
Dividend payout, bln rub 193.0 192.0 192.0 208.0   785.0
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 70.2% 30.0% 76.2% 58.3%   51.5%
OPEX, bln rub 517.0 164.0 138.0 549.0   2 463
Cost of production, bln rub 1 293 1 710 1 284 1 095   4 287
R&D, bln rub 0.000 0.000 0.000 0.000   0.000
Interest expenses, bln rub 187.0 208.0 206.0 204.0   805.0
Assets, bln rub 46 625 47 416 48 476 49 846   49 846
Net Assets, bln rub ? 12 314 12 780 13 401 13 556   13 556
Debt, bln rub 19 981 20 104 19 830 1 123   1 123
Cash, bln rub 11.0 9.00 13.0 13.0   13.0
Net debt, bln rub 19 970 20 095 19 817 1 110   1 110
Ordinary share price, rub 96.0 104.4 99.9 109.9   108.7
Number of ordinary shares, mln 270.1 270.2 271.5 276.5   276.5
Market cap, bln rub 25 940 28 203 27 112 30 393   30 056
EV, bln rub ? 45 910 48 298 46 929 31 503   31 166
Book value, bln rub 11 903 12 369 12 990 13 145   13 145
EPS, rub ? 1.02 2.37 0.93 1.29   5.51
FCF/share, rub -0.76 0.50 -0.29 -4.25   -4.71
BV/share, rub 44.1 45.8 47.8 47.5   47.5
EBITDA margin, % ? 40.7% 48.8% 47.7% 46.9%   44.1%
Net margin, % ? 12.4% 23.7% 14.1% 16.4%   17.2%
FCF yield, % ? -6.26% -4.35% -2.95% -4.36%   -4.34%
ROE, % ? 9.96% 11.0% 10.9% 11.2%   11.2%
ROA, % ? 2.63% 2.98% 3.00% 3.06%   3.06%
P/E ? 21.1 20.0 18.6 19.9   19.7
P/FCF -16.0 -23.0 -33.8 -22.9   -23.1
P/S ? 3.08 3.15 3.08 3.42   3.39
P/BV ? 2.18 2.28 2.09 2.31   2.29
EV/EBITDA ? 12.4 12.3 11.7 7.70   7.97
Debt/EBITDA 5.38 5.10 4.95 0.27   0.28
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00%   0
CAPEX/Revenue, % 48.0% 35.9% 58.1% 73.3%   52.3%
Ameren Corporation shareholders